Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Since the trade −25.6% · S&P 500 +7.4% · to Nov 20
A Myomo director paid $58K out of pocket for Myomo shares. 1 other person at Myomo bought some too, in the same month. Shares held went up 12% with this purchase.
Since the trade −27.6% · S&P 500 +7.2% · to Nov 20
A Myomo director paid $55K out of pocket for Myomo shares. 1 other person at Myomo bought some too, in the same month. Shares held went up 13% with this purchase.
Since the trade −75.6% · S&P 500 +18.3% · to Nov 20
A Myomo director paid $168K out of pocket for Myomo shares. 1 other person at Myomo bought some too, in the same month. Shares held went up 20% with this purchase.
9 open-market purchases and 6 open-market sales by insiders of MYO between Feb 7, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 9, 2026. The data provider lists the next release for Mar 8, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Harry Kovelman, Chief Medical Officer, Sep 11, 2026, about $20K. Sold 37 days after the company's previous earnings release on 2026-08-05Form 4
Milton Mayo Morris, Director, Sep 2, 2026, about $21K. Sold 28 days after the company's previous earnings release on 2026-08-05Form 4
Harry Kovelman, Chief Medical Officer, Aug 20, 2026, about $30K. Sold 15 days after the company's previous earnings release on 2026-08-05Form 4
Thomas F Kirk, Director, Jun 5, 2026, about $51K. Bought 29 days after the company's previous earnings release on 2026-05-07Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
Thomas F Kirk, Director, May 28, 2026, about $25K. Bought 21 days after the company's previous earnings release on 2026-05-07